Therefore, suppression of keratinocyte hyperproliferation, T-lymphocyte activation as well as the release of their proinflammatory mediators while inhibiting the activation of the central mTOR have proven to be useful clinical anti-psoriasis strategies (70, 73–77). This evidence concerns the gene MTOR and psoriasis.